# Cluster2-12 Analysis

## Proteins: 

AKR1C1, AKR1C2, AKR1C4, APEX2, ATOSB, BCAM, BTBD10, CAB39, CAMK4, CCDC127, CILK1, CSNK1D, CTTNBP2NL, DKC1, DMXL1, ESRRA, FAM111A, GAB1, HERC4, INO80C, JAZF1, KDM4A, KIF1B, KXD1, LRRC47, LSM7, MUS81, NECTIN2, NEDD1, NOP58, OGDHL, OTUD5, PAGE1, PARS2, POLR1A, POLR2F, PSPC1, RBMS2, RREB1, SANBR, SMARCA5, SPANXN3, STX17, SUCO, SYTL3, TAF1C, TCOF1, TIAM2, TIMM13, TMEM177, TNFRSF9, TRAF4, TRIM27, TSEN15, UBTF, ZNF174

## Title: Nucleoplasmic Protein Interaction System

### Summary

The human protein system analyzed consists of 41 proteins that are involved in protein binding, with a significant number of these proteins (24) localized in the nucleoplasm. The system is involved in various cellular processes, including DNA repair, transcription, signal transduction, and protein phosphorylation. The proteins in this system are also associated with different cellular components, such as the nucleus, cytoplasm, mitochondria, and plasma membrane. Based on the cellular location and function, the proposed name for this system is the "Nucleoplasmic Protein Interaction System."

### References

1. Gene Ontology Consortium. (2021). Gene Ontology: the framework for the model of biology. Nucleic Acids Research, 49(D1), D325-D334. [DOI: 10.1093/nar/gkaa1113](https://doi.org/10.1093/nar/gkaa1113)

2. Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., ... & Mering, C. V. (2019). STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47(D1), D607-D613. [DOI: 10.1093/nar/gky1131](https://doi.org/10.1093/nar/gky1131)

3. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., ... & Sherlock, G. (2000). Gene ontology: tool for the unification of biology. Nature Genetics, 25(1), 25-29. [DOI: 10.1038/75556](https://doi.org/10.1038/75556)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 41 | SYTL3, BCAM, STX17, TNFRSF9, FAM111A, AKR1C1, APEX2, ATOSB, BTBD10, CAB39, CILK1, CSNK1D, CTTNBP2NL, DKC1, ESRRA, GAB1, INO80C, JAZF1, KDM4A, KIF1B, KXD1, LRRC47, LSM7, MUS81, NECTIN2, NEDD1, NOP58, OGDHL, PAGE1, POLR1A, PSPC1, SMARCA5, SPANXN3, TAF1C, TCOF1, TIMM13, TMEM177, TRAF4, TRIM27, TSEN15, UBTF |
| nucleoplasm | 24 | FAM111A, APEX2, BTBD10, CAMK4, CSNK1D, DKC1, ESRRA, INO80C, JAZF1, KDM4A, LSM7, MUS81, NEDD1, NOP58, POLR1A, POLR2F, PSPC1, SMARCA5, TAF1C, TCOF1, TRAF4, TRIM27, TSEN15, UBTF |
| fibrillar center | 23 | FAM111A, APEX2, BTBD10, CAMK4, CILK1, DKC1, ESRRA, HERC4, JAZF1, KDM4A, NEDD1, NOP58, POLR2F, PSPC1, RREB1, SMARCA5, TAF1C, TCOF1, TIMM13, TRAF4, TRIM27, UBTF, ZNF174 |
| nucleus | 22 | FAM111A, APEX2, ATOSB, CAMK4, CILK1, CSNK1D, DKC1, ESRRA, JAZF1, KDM4A, LSM7, MUS81, OTUD5, POLR2F, PSPC1, RBMS2, RREB1, SMARCA5, TRAF4, TRIM27, UBTF, ZNF174 |
| cytosol | 21 | STX17, AKR1C1, AKR1C2, AKR1C4, CAB39, CILK1, CSNK1D, GAB1, HERC4, JAZF1, KDM4A, LSM7, NEDD1, NOP58, OTUD5, POLR2F, RBMS2, TCOF1, TIAM2, TRAF4, TRIM27 |
| cytoplasm | 17 | FAM111A, AKR1C4, BTBD10, CAB39, CAMK4, CILK1, CSNK1D, CTTNBP2NL, DKC1, ESRRA, GAB1, HERC4, PSPC1, RREB1, SUCO, TRAF4, TRIM27 |
| nucleolus | 9 | DKC1, MUS81, NOP58, SMARCA5, TAF1C, TCOF1, TRIM27, TSEN15, UBTF |
| extracellular exosome | 8 | BCAM, AKR1C1, AKR1C4, CAB39, CAMK4, NECTIN2, RREB1, TIAM2 |
| RNA binding | 8 | DKC1, LRRC47, LSM7, NOP58, PSPC1, RBMS2, TCOF1, UBTF |
| plasma membrane | 7 | SYTL3, BCAM, STX17, TNFRSF9, CSNK1D, NECTIN2, TRAF4 |
| mitochondrion | 7 | STX17, APEX2, KIF1B, OGDHL, PARS2, TIMM13, TRIM27 |
|  DNA-templated transcription | 7 | CAMK4, ESRRA, INO80C, PSPC1, RREB1, SMARCA5, TRIM27 |
| metal ion binding | 7 | JAZF1, MUS81, OGDHL, POLR1A, RREB1, TRIM27, ZNF174 |
| signal transduction | 6 | BCAM, CAB39, CAMK4, CILK1, CSNK1D, GAB1 |
| DNA binding | 6 | APEX2, MUS81, POLR1A, POLR2F, SMARCA5, TRIM27 |
| zinc ion binding | 6 | APEX2, ESRRA, KDM4A, TIMM13, TRAF4, TRIM27 |
| ATP binding | 6 | CAMK4, CILK1, CSNK1D, KIF1B, PARS2, SMARCA5 |
| membrane | 5 | CAB39, NECTIN2, NOP58, SUCO, TIAM2 |
| identical protein binding | 5 | NECTIN2, PARS2, SANBR, TRAF4, TRIM27 |
|  transcription by RNA polymerase II | 4 | ESRRA, RREB1, SMARCA5, ZNF174 |
| negative regulation of transcription by RNA polymerase II | 4 | JAZF1, RREB1, TRIM27, ZNF174 |
| transcription by RNA polymerase I | 4 | POLR1A, POLR2F, TAF1C, UBTF |
| apoptotic process | 3 | TNFRSF9, KIF1B, TRAF4 |
|  cell population proliferation | 3 | TNFRSF9, AKR1C2, ESRRA |
| chromatin | 3 | FAM111A, ESRRA, ZNF174 |
| alditol:NADP+ 1-oxidoreductase activity | 3 | AKR1C1, AKR1C2, AKR1C4 |
| estradiol 17-beta-dehydrogenase [NAD(P)] activity | 3 | AKR1C1, AKR1C2, AKR1C4 |
| oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 3 | AKR1C1, AKR1C2, AKR1C4 |
| bile acid binding | 3 | AKR1C1, AKR1C2, AKR1C4 |
| 17-beta-hydroxysteroid dehydrogenase (NAD+) activity | 3 | AKR1C1, AKR1C2, AKR1C4 |
| androsterone dehydrogenase activity | 3 | AKR1C1, AKR1C2, AKR1C4 |
| androstan-3-alpha,17-beta-diol dehydrogenase activity | 3 | AKR1C1, AKR1C2, AKR1C4 |
| ketosteroid monooxygenase activity | 3 | AKR1C1, AKR1C2, AKR1C4 |
| prostaglandin metabolic process | 3 | AKR1C1, AKR1C2, AKR1C4 |
| progesterone metabolic process | 3 | AKR1C1, AKR1C2, AKR1C4 |
| daunorubicin metabolic process | 3 | AKR1C1, AKR1C2, AKR1C4 |
| doxorubicin metabolic process | 3 | AKR1C1, AKR1C2, AKR1C4 |
| cellular response to jasmonic acid stimulus | 3 | AKR1C1, AKR1C2, AKR1C4 |
| peptidyl-serine phosphorylation | 3 | CAB39, CAMK4, CSNK1D |
| intracellular signal transduction | 3 | CAB39, CAMK4, CILK1 |
| protein serine kinase activity | 3 | CAMK4, CILK1, CSNK1D |
| protein phosphorylation | 3 | CAMK4, CILK1, CSNK1D |
| ciliary basal body | 3 | CILK1, CSNK1D, NEDD1 |
| DNA repair | 3 | INO80C, MUS81, SMARCA5 |
| chromatin remodeling | 3 | INO80C, KDM4A, SMARCA5 |
| negative regulation of DNA-templated transcription | 3 | KDM4A, PSPC1, ZNF174 |
| transcription by RNA polymerase II | 3 | POLR2F, RREB1, TAF1C |
| innate immune response | 3 | PSPC1, TRAF4, TRIM27 |
| intracellular protein transport | 2 | SYTL3, STX17 |
| exocytosis | 2 | SYTL3, STX17 |
| extracellular region | 2 | BCAM, CAB39 |
| external side of plasma membrane | 2 | BCAM, TNFRSF9 |
| protein kinase binding | 2 | STX17, TRAF4 |
| Golgi organization | 2 | STX17, CSNK1D |
| rough endoplasmic reticulum | 2 | STX17, SUCO |
| endoplasmic reticulum-Golgi intermediate compartment membrane | 2 | STX17, CSNK1D |
| replication fork processing | 2 | FAM111A, MUS81 |
| aldo-keto reductase (NADP) activity | 2 | AKR1C1, AKR1C4 |
| phenanthrene 9,10-monooxygenase activity | 2 | AKR1C1, AKR1C2 |
| carboxylic acid binding | 2 | AKR1C1, AKR1C2 |
| dihydrotestosterone 17-beta-dehydrogenase activity | 2 | AKR1C1, AKR1C4 |
| 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2 | AKR1C1, AKR1C4 |
| testosterone 17-beta-dehydrogenase (NADP+) activity | 2 | AKR1C1, AKR1C4 |
| trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 2 | AKR1C1, AKR1C2 |
| indanol dehydrogenase activity | 2 | AKR1C1, AKR1C2 |
| retinoid metabolic process | 2 | AKR1C1, AKR1C4 |
| digestion | 2 | AKR1C1, AKR1C2 |
| bile acid and bile salt transport | 2 | AKR1C1, AKR1C4 |
| epithelial cell differentiation | 2 | AKR1C1, AKR1C2 |
| steroid metabolic process | 2 | AKR1C2, AKR1C4 |
| endonuclease activity | 2 | APEX2, MUS81 |
| DNA recombination | 2 | APEX2, INO80C |
|  osteoclast differentiation | 2 | CAMK4, ESRRA |
| protein kinase activity | 2 | CILK1, CSNK1D |
| protein serine/threonine kinase activity | 2 | CILK1, CSNK1D |
| microtubule nucleation | 2 | CSNK1D, NEDD1 |
|  circadian rhythm | 2 | CSNK1D, PSPC1 |
| centrosome | 2 | CSNK1D, NEDD1 |
| neuron projection | 2 | CSNK1D, KIF1B |
| perinuclear region of cytoplasm | 2 | CSNK1D, TRAF4 |
| lamellipodium | 2 | CTTNBP2NL, TIAM2 |
| rRNA processing | 2 | DKC1, NOP58 |
| RNA processing | 2 | DKC1, RBMS2 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 2 | ESRRA, ZNF174 |
| DNA-binding transcription factor activity | 2 | ESRRA, ZNF174 |
| sequence-specific DNA binding | 2 | ESRRA, ZNF174 |
| sequence-specific double-stranded DNA binding | 2 | ESRRA, ZNF174 |
|  osteoblast differentiation | 2 | ESRRA, SUCO |
| cell-cell junction | 2 | GAB1, NECTIN2 |
| ubiquitin protein ligase activity | 2 | HERC4, TRIM27 |
| spermatogenesis | 2 | HERC4, TRIM27 |
|  DNA replication | 2 | INO80C, SMARCA5 |
| ubiquitin protein ligase binding | 2 | KDM4A, TRAF4 |
| negative regulation of autophagy | 2 | KDM4A, TRIM27 |
| pericentric heterochromatin | 2 | KDM4A, SMARCA5 |
| ATP hydrolysis activity | 2 | KIF1B, SMARCA5 |
| vesicle-mediated transport | 2 | KIF1B, KXD1 |
| nuclear replication fork | 2 | MUS81, SMARCA5 |
| protein homodimerization activity | 2 | NECTIN2, ZNF174 |
| mitochondrial matrix | 2 | OGDHL, PARS2 |
| negative regulation of type I interferon production | 2 | OTUD5, TRIM27 |
| RNA polymerase I activity | 2 | POLR1A, POLR2F |
| chromatin binding | 2 | POLR1A, UBTF |
| RNA polymerase I complex | 2 | POLR1A, POLR2F |
| nuclear speck | 2 | PSPC1, RREB1 |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2 | RREB1, ZNF174 |
| nuclear body | 2 | RREB1, ZNF174 |
|  transcription by RNA polymerase I | 2 | SMARCA5, UBTF |
| RNA polymerase I core promoter sequence-specific DNA binding | 2 | TAF1C, UBTF |
| RNA polymerase I general transcription initiation factor activity | 2 | TAF1C, UBTF |
| RNA polymerase I preinitiation complex assembly | 2 | TAF1C, UBTF |
| transcription initiation at RNA polymerase I promoter | 2 | TAF1C, UBTF |
| scaffold protein binding | 2 | TCOF1, UBTF |
| mitochondrial inner membrane | 2 | TIMM13, TMEM177 |
| protein K63-linked ubiquitination | 2 | TRAF4, TRIM27 |
| nucleic acid binding | 2 | TRIM27, TSEN15 |

